In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis
- PMID: 6805422
- PMCID: PMC181846
- DOI: 10.1128/AAC.21.1.166
In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis
Abstract
BRL 17421, a novel beta-lactam antibiotic, was tested in vitro against fastidious gram-negative bacteria and compared with amoxicillin and amoxicillin plus clavulanic acid. The compound showed good activity against Haemophilus influenzae (range of minimal inhibitory concentrations, 0.2 to 1 microgram/ml), Neisseria gonorrhoeae (0.007 to 0.5 microgram/ml), and Branhamella catarrhalis (0.03 to 0.1 microgram/ml). BRL 17421 exhibited excellent stability against the TEM-type beta-lactamase of H. influenzae and N. gonorrhoeae, and its activity was little affected by inoculum size. Minimal lethal concentrations of BRL 17421 for 10(7) colony-forming units of H. influenzae ranged between 0.5 and 4 micrograms/ml.
Similar articles
-
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.Eur J Clin Microbiol. 1986 Dec;5(6):615-21. doi: 10.1007/BF02013284. Eur J Clin Microbiol. 1986. PMID: 3492374
-
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.J Antimicrob Chemother. 1980 Mar;6(2):197-206. doi: 10.1093/jac/6.2.197. J Antimicrob Chemother. 1980. PMID: 6247316 No abstract available.
-
In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):349-52. doi: 10.1016/0732-8893(90)90030-y. Diagn Microbiol Infect Dis. 1990. PMID: 2127558
-
Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.Antimicrob Agents Chemother. 1988 Dec;32(12):1747-53. doi: 10.1128/AAC.32.12.1747. Antimicrob Agents Chemother. 1988. PMID: 3149883 Free PMC article. Review. No abstract available.
-
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.Am J Med. 1985 Nov 29;79(5B):2-12. doi: 10.1016/0002-9343(85)90123-8. Am J Med. 1985. PMID: 3907341 Review.
Cited by
-
In vitro activity of temocillin against clinical isolates.Drugs. 1985;29 Suppl 5:1-8. doi: 10.2165/00003495-198500295-00003. Drugs. 1985. PMID: 4029009
-
In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.Antimicrob Agents Chemother. 1982 Oct;22(4):535-40. doi: 10.1128/AAC.22.4.535. Antimicrob Agents Chemother. 1982. PMID: 7181470 Free PMC article.
-
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.Antibiotics (Basel). 2022 Apr 7;11(4):493. doi: 10.3390/antibiotics11040493. Antibiotics (Basel). 2022. PMID: 35453244 Free PMC article. Review.
-
Interpretive criteria for temocillin disk diffusion susceptibility testing.Eur J Clin Microbiol. 1985 Feb;4(1):30-3. doi: 10.1007/BF02148656. Eur J Clin Microbiol. 1985. PMID: 3872793
-
Temocillin. In vitro activity compared with other antibiotics.Drugs. 1985;29 Suppl 5:91-7. doi: 10.2165/00003495-198500295-00018. Drugs. 1985. PMID: 3875477
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical